P. Pietrangeli et al., ENHANCEMENT OF DAUNOMYCIN TOXICITY BY THE DIFFERENTIATION INDUCER HEXAMETHYLENE BISACETAMIDE IN ERYTHROLEUKEMIA-CELLS, Biochimica et biophysica acta. Molecular cell research, 1224(1), 1994, pp. 89-98
Cytotoxic effects of daunomycin were investigated upon differentiation
of Friend erythroleukemia cells induced with hexamethylene bisacetami
de, a process during which a 20-fold increase in the hemoglobin conten
t occurred. Daunomycin proved to be more toxic to differentiated Frien
d cells than to their undifferentiated counterparts. No changes in the
daunomycin uptake rates of the two cell types were detectable. Extern
ally added catalase and desferrioxamine mesylate protected against the
additional cytotoxicity of daunomycin in differentiated cells, pointi
ng to hydrogen peroxide and iron ions as mediators of the toxic effect
. Daunomycin-dependent, cyanide-insensitive oxygen consumption of cont
rol and induced cells did not differ significantly, and the rate of fo
rmation of the daunomycin semiquinone radical electron paramagnetic re
sonance signal was similar in both cell types, indicating that the dif
ference in toxicity was not due to increased drug activation by plasma
membrane enzymes. Differentiated cells had a lowered catalase content
; the cellular iron content was shown to increase by 2.8-fold upon cel
l differentiation, with hemoglobin-bound iron being about 50% of the t
otal. Altogether, the results suggest increased intracellular hydrogen
peroxide generation mediated by hemoglobin, combined with a decrease
in catalase activity and an increase in accessible iron, as responsibl
e for the higher sensitivity to daunomycin shown by differentiated Fri
end cells. This represents the first experimental system where the inc
rease in anthracycline cytotoxicity upon cell differentiation can be a
ttributed to redox activation and the formation of reactive oxygen spe
cies.